EMEA-000669-PIP01-09-M02 - paediatric investigation plan
Split influenza virus, inactivated containing antigen equivalent to A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-179A)), adjuvanted
PIPHuman
Sanofi Pasteur SA
E-mail: Piplan@sanofipasteur.com
Country: France
Phone: +33 437375038
P/0022/2019: EMA decision of 4 January 2019 on the acceptance of a modification of an agreed paediatric investigation plan for split influenza virus, inactivated containing antigen equivalent to A/California/7/2009(H1N1)-like strain (A/California/7/2009 (